Showing results (151-160 of 181) with videos related to
Sort By:
Pageof 19
Journal of Medicinal Chemistry|December 6, 2024
Discovery of a Novel Non-invasive AR PROTAC Degrader for the Topical Treatment of Androgenetic AlopeciaXinfei Mao, Weitong Hu, Mingfei Wu, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 9, 2024
Blocking Ubiquitin-Specific Protease 7 Induces Ferroptosis in Gastric Cancer via Targeting Stearoyl-CoA DesaturaseXiaoqing Guan, Yichao Wang, Wenkai Yu, et al.Acta Pharmaceutica Sinica. B|January 13, 2022
Deubiquitinase JOSD2 stabilizes YAP/TAZ to promote cholangiocarcinoma progressionMeijia Qian, Fangjie Yan, Weihua Wang, et al.Journal of Medicinal Chemistry|June 24, 2024
Discovery of a Highly Potent and Selective BRD9 PROTAC Degrader Based on E3 Binder Investigation for the Treatment of Hematological TumorsHaiting Duan, Jingyu Zhang, Renzhao Gui, et al.Journal of Medicinal Chemistry|September 30, 2025
Discovery of a Selective and Potent BCL6 PROTAC with Efficacious Antiproliferative Activity for the Treatment of Diffuse Large B-Cell LymphomaXiaoli Yu, Xueyan Liao, Jingyu Zhang, et al.The American Journal of Gastroenterology|April 8, 2024
Associations of Intrapancreatic Fat Deposition With Incident Diseases of the Exocrine and Endocrine Pancreas: A UK Biobank Prospective Cohort StudyXiaowu Dong, Qingtian Zhu, Chenchen Yuan, et al.Journal of Medicinal Chemistry|May 16, 2025
Discovery of a New and Selective HPK1 PROTAC for Enhancing Tumor Immunotherapy through Eliminating GLK DegradationMingfei Wu, Xinfei Mao, Yiquan Wu, et al.Journal of Advanced Research|February 3, 2026
Screening and identification of a novel PGAM5-specific inhibitor for attenuating multi-organ injuryLin Chen, Haibo Li, Qingtain Zhu, et al.Journal of Medicinal Chemistry|March 5, 2026
Nitroimidazole-Containing [68Ga]Ga-IPM-N001 as a New CAIX-Targeting Radionuclide TracerXiaoke Niu, Sixuan Cheng, Shengping Zhang, et al.Journal of the American Chemical Society|January 10, 2026
Stability and Degradation-based Proteome Profiling Reveals Cannabidiol as a Promising CDC123-eIF2γ Inhibitor for Colorectal Cancer TherapyHengyuan Yu, Yang Chen, Mingfei Wu, et al.Pageof 19